① What is Combrog Tab?
Combrog Tab is a combination medication used to treat dyslipidemia.
It contains two active ingredients: Rosuvastatin Calcium and Ezetimibe.
Each works via a different mechanism to effectively lower LDL cholesterol levels.
Rosuvastatin inhibits cholesterol synthesis in the liver, while Ezetimibe blocks intestinal absorption of cholesterol.
This dual approach enables a stronger and faster LDL-C reduction than using either component alone.
② Active Ingredients and Mechanism of Action
- Rosuvastatin:
As an HMG-CoA reductase inhibitor (statin), it reduces cholesterol synthesis in the liver and increases LDL receptor expression, promoting LDL clearance. - Ezetimibe:
It blocks NPC1L1, a protein responsible for cholesterol absorption in the intestines.
This inhibits the uptake of both dietary and biliary cholesterol.
Together, these mechanisms provide enhanced lipid-lowering effects for patients requiring aggressive control.
③ Therapeutic Effects and Expected Benefits
- Significant LDL-C Reduction
Compared to monotherapy, the combination offers an additional 15–25% LDL-C reduction, with possible reductions exceeding 50% in high-risk patients. - Prevention of Cardiovascular Disease
Lowering LDL-C helps reduce the risk of heart attack, stroke, and atherosclerosis.
Combrog Tab is a key player in cardiovascular risk reduction. - For Primary and Secondary Prevention
Useful for patients not achieving targets with statins alone, and for those with a history of cardiovascular events (secondary prevention).
④ Side Effects and Precautions
- Muscle-Related Issues
Rare cases of myalgia, myopathy, or rhabdomyolysis may occur.
Symptoms like muscle weakness, dark urine, or fatigue warrant immediate medical attention. - Liver Function Abnormalities
Liver enzymes may rise, especially with long-term use. Routine liver function tests (AST, ALT) are recommended. - Gastrointestinal Symptoms and Headache
Some patients may experience mild abdominal discomfort, diarrhea, or headaches, which are usually transient. - Not Recommended for Pregnant or Breastfeeding Women
Due to potential harm to the fetus, women of childbearing age must use contraception during treatment.
⑤ Related Foods and Nutritional Considerations
- For Rosuvastatin:
Reduce saturated and trans fats. Increase intake of omega-3-rich fatty fish like salmon and mackerel to support heart health. - For Ezetimibe:
- High-fiber foods (oats, barley, legumes) help bind and eliminate bile acids and cholesterol.
- Plant sterol–rich foods (broccoli, sunflower seeds, almonds) help block cholesterol absorption in the gut.
Combining these dietary approaches with Combrog Tab enhances lipid control and long-term outcomes.
⑥ Summary
Combrog Tab is a fixed-dose combination of a statin (rosuvastatin) and ezetimibe, providing a strong, dual-action treatment for high LDL cholesterol.
It is especially effective for patients who fail to reach lipid targets with statins alone or those in high-risk categories.
Monitoring for muscle symptoms, liver function, and digestive issues is important.
With proper blood tests and dietary management, Combrog Tab offers optimal control of dyslipidemia.